Product Overview: Anadrol 50 Oxymetholone Maha Pharma
Anadrol 50 Oxymetholone is a potent synthetic anabolic-androgenic steroid derived from dihydrotestosterone, manufactured by Maha Pharma for research applications. This oral compound exhibits significant anabolic properties through its interaction with androgen receptors, making it valuable for investigating muscle tissue development, protein synthesis mechanisms, and hormonal pathway modulation in controlled laboratory settings. Researchers examining anabolic steroid pharmacology frequently evaluate this compound alongside other Stroid UK Shop to understand its unique molecular characteristics and tissue-specific effects.
Laboratory Applications
Scientific investigations utilise Oxymetholone to study various biological processes including erythropoiesis stimulation, nitrogen retention mechanisms, and androgenic receptor activation patterns. Its pronounced effects on red blood cell production make it particularly relevant for haematological research, while its anabolic properties provide insights into muscle protein synthesis pathways. Researchers often compare its activity profile against compounds found in our Anadrol collection to evaluate potency variations and structure-activity relationships. Studies examining its hepatic metabolism and oral bioavailability contribute to understanding steroid pharmacokinetics, while investigations into its effects on cellular growth factors advance knowledge of anabolic mechanisms.
Research Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 17β-Hydroxy-2-(hydroxymethylene)-17α-methyl-5α-androstan-3-one |
| CAS Number | 434-07-1 |
| Molecular Formula | C₂₁H₃₂O₃ |
| Molecular Weight | 332.48 g/mol |
| Form | Oral tablets |
| Strength | 50mg per tablet |
| Manufacturer | Maha Pharma |
| Storage | Room temperature, dry environment |
This compound’s distinct molecular structure, featuring a 17α-methyl group and 2-hydroxymethylene substitution, differentiates it from other anabolic steroids in research applications. Its oral activity and resistance to hepatic metabolism make it suitable for studying first-pass effects and bioavailability factors. Comparison studies with SARMs and peptides provide comprehensive data on different anabolic mechanisms and receptor selectivity patterns.
Research Compliance
This product is intended exclusively for in-vitro research applications and is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this compound. All investigations should be conducted within appropriate research facilities with proper safety equipment and waste disposal procedures.
